SEARCH RESULTS for assignee:"io therapeutics"

Showing 1 to 17 of 17 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 16034123: IMMUNOMODULATORY AND DIFFERENTIATING FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(A1) 20180338940: IMMUNOMODULATORY AND DIFFERENTIATING FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 16050441: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(A1) 20180338941: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 16034123: IMMUNOMODULATORY AND DIFFERENTIATING FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(A1) 20180338940: IMMUNOMODULATORY AND DIFFERENTIATING FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15770737: TREATMENT OF NERVOUS SYSTEM DISORDERS USING THYROID HORMONE NEUTRAL DOSES OF RXR AGONISTS

(A1) 20180318241: TREATMENT OF NERVOUS SYSTEM DISORDERS USING THYROID HORMONE NEUTRAL DOSES OF RXR AGONISTS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15988965: AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS

(A1) 20180263939: AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15629591: TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS

(A1) 20170281576: TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS

(B2) 1: TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15629591: TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS

(A1) 20170281576: TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS

(B2) 1: TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14626339: Autoimmune Disorder Treatment Using RXR Agonists

(A1) 20150196517: Autoimmune Disorder Treatment Using RXR Agonists

(B2) 1: Autoimmune Disorder Treatment Using RXR Agonists

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15868391: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(A1) 20180133179: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15868432: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(A1) 20180133180: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15868450: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(A1) 20180133181: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15868459: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(A1) 20180133182: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15868469: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(A1) 20180133183: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15852580: AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS

(A1) 20180116985: AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15812821: TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

(A1) 20180064670: TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15620411: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(A1) 20170354623: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

(B2) 9: RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15339752: TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

(A1) 20170119713: TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

(B2) 9: TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

Assignee(s)